1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, Muñoz García M, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M, Cruz-Jentoft AJ.

    [Spanish version of the STOPP/START 3 criteria: Advances in the detection of inappropriate prescribing medication in the older people].

    Revista espanola de geriatria y gerontologia . 58(5): 101407-101407.

    [doi:10.1016/j.regg.2023.101407]

  • Ojeda IM, Sánchez-Cuervo M, Candela-Toha Á, Serrano-López DR, Bermejo-Vicedo T, Alcaide-López-de-Lerma JM.

    Protocolization of Analgesia and Sedation Through Smart Technology in Intensive Care: Improving Patient Safety.

    CRITICAL CARE NURSE . 43(4): 30-38.

    [doi:10.4037/ccn2023271]

  • García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

    HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health . 11: 1136988-1136988. Number of citations: 6

    [doi:10.3389/fpubh.2023.1136988]

  • Velez-Diaz-Pallares, M, Esteban-Cartelle, B, Gramage-Caro, T, Montero-Llorente, B, Parro-Martin, MD, Rodriguez-Sagrado, MA, Alvarez-Diaz, AM.

    Disorders in sleep quality associated with integrase inhibitors in the treatment of HIV

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .

  • Vélez-Díaz-Pallarés M, Esteban-Cartelle B, Gramage-Caro T, Montero-Llorente B, Parro-Martín MLÁ, Rodríguez-Sagrado MÁ, Álvarez-Díaz AM.

    Trastornos en la calidad del sueño asociados a los inhibidores de la integrasa en el tratamiento del VIH.

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .

  • Rosas Cancio-Suárez M, Alonso C, Vivancos MJ, Pérez-Elías MJ, Cárdenas MJ, Vélez-Díaz-Pallarés M, Corbacho MD, Martín-Pedraza L, Muriel A, Martínez-Sanz J, Moreno S.

    Impact of COVID-19 on the Care of Patients with HIV Infection.

    Journal Of Clinical Medicine . 12(12): . Number of citations: 4

    [doi:10.3390/jcm12123882]

  • Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, Quereda Rodríguez-Navarro C, Álvarez-Díaz AM, Saez de la Fuente J.

    Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . 31(6): 532-536. Number of citations: 1

    [doi:10.1136/ejhpharm-2023-003729]

  • Morillo Verdugo R, Bernardez Ferrán B, Fernández Polo A, Margusino Framiñan L, Martínez Sesmero JM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    Prioritization of initiatives 2024-2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital Pharmacy.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2024.03.013]

  • Colomer Aguilar C, Negro-Vega E, Fernández de Gamarra-Martínez E, Martínez Castro B, Pérez Abánades M, Redondo Capafons S, Pérez Menéndez Conde C.

    Map of the residency rotations for hospital pharmacy internal resident in Spain.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.03.014]

  • Alfonsín Lara M, Áreas Del Águila V, Contreras Macías E, Mancebo González A, Martínez Castro B, Pérez Menéndez-Conde C, Sanmartín Fenollera P, Morillo-Verdugo R.

    Knowledge, perception and predisposition to implement the MAPEX strategy in hospital pharmacy residents in Spain. FIRMAPEX project.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.04.007]

  • Martínez-Barros H, Muñoz-García M, Antolín-Amérigo D, Sánchez-Cuéllar S, Morales-Tirado A, de-Andrés-Martín A, De-Los-Santos-Granados G, Yeguas-Ramírez L, Blitz-Castro E, Santamaría-Gadea A, de-la-Hoz-Caballer B, Martín-Aragón S, González-de-Olano D, Álvarez-Díaz AM.

    Designing a patient onboarding in a multidisciplinary severe asthma unit.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.07.003]

  • Valdeolmillos Carbó LV, Esteban Gómez MJ, Ruiz-Jarabo Gómez I, Ribed Sánchez A, Vicente Oliveros N, Guisado Gil AB, Campino Villegas A, Campillos P, Olier Martínez P, de Pourcq JT.

    Guidelines on the perioperative management of chronic medication in surgical patients.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.07.002]

  • Vélez-Díaz-Pallarés M, Parro-Martín MÁ, Martínez-Barros H, Montero-Llorente B, Menacho-Román M, Gómez-Lozano A, Royo RN, Carro LM, Álvarez-Díaz A.

    Biochemical characteristics of inhaled antibiotics related to tolerability.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.08.007]

  • Alfonsín Lara M, Áreas Del Águila V, Contreras Macías E, Mancebo González A, Martínez Castro B, Pérez Menéndez-Conde C, Sanmartín Fenollera P, Morillo-Verdugo R.

    [Translated article] Knowledge, perception and predisposition to implement the MAPEX strategy in hospital pharmacy residents in Spain. FIRMAPEX project.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2025.10.001]